Skip to main content

Table 3 Treatments and hospitalizations for patients within 1 year after lung cancer diagnosis

From: Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study

N (%)

 

Total (N = 2553)

Before VTE (N = 208)

Before PE (N = 93)

Before bleeding (N = 341)

Lung cancer surgery

No

2052 (80.4)

181 (87.0)

83 (89.3)

280 (82.1)

 

Yes

501 (19.6)

27 (13.0*)

10 (10.8)

61 (17.9)

Other surgery

No

1970 (77.2)

156 (75.0)

73 (78.5)

279 (81.8)

 

Yes

583 (22.8)

52 (25.0)

20 (21.5)

62 (18.2)

Chemotherapy

No

1201 (47.0)

72 (34.6)

35 (37.6)

217 (63.6)

 

Yes

1352 (53.0)

136 (65.4)

58 (62.4)

124 (36.4)

+ Bevacizumab

No

1244 (92.0)

125 (91.9)

55 (91.4)

117 (94.4)

 

Yes

108 (8.0)

11 (8.1)

3 (8.6)

7 (5.7)

Oral lung cancer targeted therapy

No

2340 (91.7)

201 (96.6)

87 (93.6)

333 (97.7)

 

Yes

213 (8.3)

7 (3.4)

6 (6.5)

8 (2.4)

Radiotherapy

No

1711 (67.0)

155 (74.5)

68 (73.1)

274 (80.4)

 

Yes

842 (33.0)

53 (25.5)

25 (26.9)

67 (19.7)

Blood transfusion

No

2253 (88.3)

190 (91.4)

86 (92.5)

290 (85.0)

 

Yes

300 (11.8)

18 (8.7)

7 (7.5)

51 (15.0)

Non-surgical hospitalisation†

No

1065 (41.7)

122 (58.7)

52 (55.9)

 
 

Yes

1488 (58.3)

86 (41.4)

41 (44.1)

 
  1. *Among patients with VTE, 13.0% underwent lung cancer surgery after the diagnosis of cancer and before the diagnosis of VTE
  2. †Non-surgical stay of more than 2 nights